Company intelligence / Profile preview

U-Protein Express

Utrecht, Utrecht, Netherlandsuu.nl ↗

Ownership: Private
Development stage: Commercial

Overview

U-Protein Express is a leading CRO specializing in the fast and large-scale production of mammalian recombinant proteins and antibodies for research and pre-clinical applications. It operates as a wholly-owned subsidiary of ImmunoPrecise Antibodies since its acquisition in August 2017. The company holds exclusive rights to proprietary expression technologies and has an exclusive license from Stanford University to manufacture Wnt surrogate Fc growth factor for organoid culture.

Modalities: Recombinant proteinMonoclonal antibodyBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on U-Protein Express.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on U-Protein Express.

Explore the full profile